Correlation Between Helix BioPharma and Oncolytics Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Helix BioPharma and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Helix BioPharma and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Helix BioPharma Corp and Oncolytics Biotech, you can compare the effects of market volatilities on Helix BioPharma and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Helix BioPharma with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Helix BioPharma and Oncolytics Biotech.

Diversification Opportunities for Helix BioPharma and Oncolytics Biotech

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Helix and Oncolytics is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Helix BioPharma Corp and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Helix BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Helix BioPharma Corp are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Helix BioPharma i.e., Helix BioPharma and Oncolytics Biotech go up and down completely randomly.

Pair Corralation between Helix BioPharma and Oncolytics Biotech

Assuming the 90 days trading horizon Helix BioPharma Corp is expected to generate 1.28 times more return on investment than Oncolytics Biotech. However, Helix BioPharma is 1.28 times more volatile than Oncolytics Biotech. It trades about 0.03 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.01 per unit of risk. If you would invest  100.00  in Helix BioPharma Corp on November 4, 2024 and sell it today you would lose (8.00) from holding Helix BioPharma Corp or give up 8.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Helix BioPharma Corp  vs.  Oncolytics Biotech

 Performance 
       Timeline  
Helix BioPharma Corp 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Helix BioPharma Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Helix BioPharma displayed solid returns over the last few months and may actually be approaching a breakup point.
Oncolytics Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Helix BioPharma and Oncolytics Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Helix BioPharma and Oncolytics Biotech

The main advantage of trading using opposite Helix BioPharma and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Helix BioPharma position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.
The idea behind Helix BioPharma Corp and Oncolytics Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device